International opinions and national surveillance suggest insufficient consensus regarding the recognition and management practices of infants with congenital cytomegalovirus infections

Acta Paediatrica, International Journal of Paediatrics

Volumn 106, Issue 9, 2017, Pages 1493-1498

  Gunkel, J ^a   Nijman, J ^a   Verboon Maciolek, M A ^a   Wolfs, T F W ^a   de Vries, L S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Congenital infection; Cytomegalovirus; Management practices; National surveillance; Questionnaire

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; AUDIOLOGY; CLINICAL ARTICLE; CLINICAL PRACTICE; CONGENITAL INFECTION; CONSENSUS DEVELOPMENT; CYTOMEGALOVIRUS INFECTION; DISEASE SURVEILLANCE; DUTCHMAN; ECHOENCEPHALOGRAPHY; FOLLOW UP; HEARING IMPAIRMENT; HEPATOSPLENOMEGALY; HUMAN; HYPERTRANSAMINASEMIA; INFANT; INFANT CARE; INFANT DISEASE; MATERNAL CARE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICIAN; PRIORITY JOURNAL; SCREENING TEST; FEMALE; HEARING TEST; MASS SCREENING; NEONATOLOGY; NETHERLANDS; NEWBORN; PREGNANCY; QUESTIONNAIRE; STANDARDS; STATISTICS AND NUMERICAL DATA;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEARING TESTS; HUMANS; INFANT; INFANT, NEWBORN; MASS SCREENING; NEONATOLOGY; NETHERLANDS; NEUROIMAGING; PREGNANCY; SURVEYS AND QUESTIONNAIRES;

EID: 85026919906     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.13882     Document Type: Article

References (25)

1. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17: 355–63.
2. Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr 1999; 135: 60–4.
3. Korndewal M, Vossen A, Cremer J, Van Binnendijk R, Kroes A, Van Der Sande M, et al. Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence. Epidemiol Infect 2016; 144: 1520–7.
4. Cannon M, Davis K. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005; 5: 1–8.
5. Britt W. Cytomegalovirus. In: JA Fletcher, R Miller, editors. Remington and Klein's infectious diseases of the fetus and newborn infant, 7th ed. Philadelphia, PA: Elsevier Saunders, 2008: 730–6.
6. Revello MG, Tibaldi C, Masuelli G, Frisina V, Sacchi A, Furione M, et al. Prevention of primary cytomegalovirus infection in pregnancy. EBioMedicine 2015; 2: 1205–10.
7. Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015; 372: 933–43.
8. Korver A, de Vries J, de Jong J, Dekker F, Vossen A, Oudesluys-Murphy A. Awareness of congenital cytomegalovirus among doctors in the Netherlands. J Clin Microbiol 2009; 46S: S11–5.
9. Pereboom MTR, Manniën J, Spelten ER, Hutton EK, Schellevis FG. Maternal cytomegalovirus infection prevention: the role of Dutch primary care midwives. Midwifery 2014; 30: 1196–201.
10. Kenneson A, Cannon M. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17: 253–76.
11. Munro SC, Trincado D, Hall B, Rawlinson WD. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health 2005; 41: 449–52.
12. Townsend C, Peckham C, Tookey P. Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 2011; 96: F398–403.
13. Vaudry W, Lee BE, Rosychuk RJ. Congenital cytomegalovirus infection in Canada: active surveillance for cases diagnosed by paediatricians. Paediatr Child Heal 2014; 19: 1–5.
14. Zeitlin J, Manktelow BN, Piedvache A, Cuttini M, Boyle E, van Heijst A, et al. Use of evidence based practices to improve survival without severe morbidity for very preterm infants: results from the EPICE population based cohort. BMJ 2016; 354: i2976.
15. Gunkel J, Wolfs T, Nijman J, Schuurman R, Verboon-Maciolek M, de Vries L, et al. Urine is superior to saliva when screening for postnatal CMV infections in preterm infants. J Clin Virol 2014; 61: 61–4.
16. Averill L, Kandula V, Akyol Y, Epelman M. Fetal brain magnetic resonance imaging infection with postnatal imaging correlation. Semin Ultrasound CT MR 2015; 36: 476–86.
17. Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011; 2011: 1–9.
18. de Vries J, Vossen A, Kroes A, van der Zeijst B. Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers. Rev Med Virol 2011; 21: 54–61.
19. Purcell PL, Shinn JR, Davis GE, Sie KCY. Children with unilateral hearing loss may have lower intelligence quotient scores: a meta-analysis. Laryngoscope 2016; 126: 746–54.
20. Moeller MP. Early intervention and language development in children who are deaf and hard of hearing. Pediatrics 2000; 106: 1–9.
21. Oosterom N, Nijman J, Gunkel J, Wolfs T, Groenendaal F, Verboon-Maciolek M, et al. Neuro-imaging findings in infants with congenital cytomegalovirus infection: relation to trimester of infection. Neonatology 2015; 107: 289–96.
22. Centraal Bureau voor de Statistiek. Geboorte; kerncijfers [Internet]. Available from: http://statline.cbs.nl/ (accessed on November 18, 2016).
23. Townsend C, Forsgren M, Ahlfors K, Ivarsson S-A, Tookey P, Peckham C. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis 2013; 56: 1232–9.
24. Ross S, Boppana S. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 2005; 16: 44–9.
25. Revello M, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15: 680–715.